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Available online 16 August 2018Sleep disturbance is common among individuals at risk of psychosis, yet few studies have investigated the relationship
between sleep disturbance and clinical trajectory. The Early Detection and Intervention Evaluation (EDIE-2) trial pro-
vides longitudinal data on sleep duration and individual psychotic experiences from a cohort of individuals at risk of
psychosis, which this study utilises in an opportunistic secondary analysis. Shorter and more variable sleep was
hypothesised tobe associatedwithmore severe psychotic experiences and lowerpsychologicalwellbeing.Mixed effect
models were used to test sleep duration and range as predictors of individual psychotic experiences and psychological
wellbeing over the 12–24months (with assessments every 3months) in 160 participants. Shorter sleep durationwas
associated with more severe delusional ideas and hallucinations cross-sectionally and longitudinally. The longitudinal
relationships did not remain signiﬁcant after conservative controls were added for the previous severity of psychotic
experiences. No signiﬁcant relationships were found between the sleep variables and other psychotic experiences
(e.g. cognitive disorganisation), or psychological wellbeing. The results support a relationship between shorter sleep
duration anddelusional ideas andhallucinations. Future studies should focus on improving sleepdisturbancemeasure-
ment, and test whether treating sleep improves clinical trajectory in the at-risk group.
© 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
At risk
Sleep
Psychosis
Longitudinal1. Introduction
A causal role for sleep disturbance in contributing to psychotic expe-
riences has recently begun to emerge (Reeve et al., 2015). It has been
demonstrated that reducing sleep increases psychotic experiences
(Reeve et al., 2018), and that treating insomnia improves psychotic ex-
periences (Freeman et al., 2017). Sleep disorders have also been shown
to be common and severe, but treatable, among individuals with psy-
chotic disorders (Freeman et al., 2009, 2015). However there has been
a surprising lack of research speciﬁcally investigating the causal contri-
bution of sleep disturbance to psychotic experiences in at-risk individ-
uals (Davies et al., 2016; Reeve et al., 2015; Zanini et al., 2013). This is
despite a longstanding clinical awareness of sleep disturbance as a risk
indicator for transition from the at-risk state to psychosis (Keshavan
et al., 2004; Ruhrmann et al., 2010)niversity of Oxford, Warneford
.
. This is an open access article underExisting research does indicate that sleep abnormalities are common
in individuals at-risk of psychosis. Between 37% and 78% of this popula-
tion have been found to report sleep disturbance, as assessed on the
Scale of Assessment of Positive Symptoms (SAPS) across several studies
(Miller et al., 2003; Poe et al., 2017). Reporting sleep disturbance has
also been found to be highly predictive of transition to psychotic epi-
sode in the following 18 month period (Ruhrmann et al., 2010). How-
ever, ‘sleep disturbance’ is a broad term comprising a range of sleep
disorders and disturbances (e.g. insomnia, circadian rhythm disruption,
nightmares). This in turn hinders further research on how sleep distur-
bance in this group may contribute to psychotic experiences or transi-
tion to psychosis, or how it may be clinically addressed. In contrast,
sleep recording studies have identiﬁed a range of speciﬁc sleep abnor-
malities in individuals at-risk of psychosis, including longer sleep
onset latency, reduced sleep efﬁciency, and increased circadian rhythm
disturbance in comparison to non-clinical controls (Lunsford-Avery
et al., 2015; Zanini et al., 2015). These objective sleep disturbances
have been linked with increased positive symptoms both at baselinethe CC BY license (http://creativecommons.org/licenses/by/4.0/).
327S. Reeve et al. / Schizophrenia Research 204 (2019) 326–333andat 12month followup(Lunsford-Avery et al., 2015, 2016). In summary,
research to date supports that sleep disturbance is commonand relevant to
clinical trajectory in psychosis, yet there needs to be further consensus on
which sleep variables are relevant in this relationship. Especially valuable
would be identiﬁcation of speciﬁc self-reported sleep disturbances that
are predictive of psychotic experiences, given the lack of access to objective
sleep recording measures in standard clinical services.
One shortcoming across this literature has been themeasurement of
psychosis; in all the studies discussed above individual psychotic expe-
riences were grouped together under the measurement of positive
symptoms. However, multiple sources of evidence indicate that para-
noia, hallucinations, grandiosity, and cognitive disorganisation exist as
independent continua in the population with somewhat differing risk,
development, and maintenance factors (Ronald, 2015; van Os, 2014;
Zavos et al., 2014). Furthermore, as reported in a recent experimental
study, sleep loss affects the dimensions of psychotic experience differ-
ently, with signiﬁcant effects on hallucinations, paranoia, and cognitive
disorganisation, but no effect on grandiosity (Reeve et al., 2018). There-
fore, measuring individual psychotic experience dimensions may allow
a clearer picture to emerge of the relationships between sleep distur-
bance and psychotic experiences in the at-risk population.
1.1. The Early Detection and Intervention Evaluation Trial (EDIE-2)
The EDIE-2 trial datamay provide an opportunity to address some of
these issues. EDIE-2 was a multi-site randomised controlled trial of a
psychological intervention aiming to reduce transition to psychosis
(Morrison et al., 2011, 2012). A large cohort of individuals at risk for
psychosis (n = 288) were recruited from ﬁve sites in the UK, and
randomised such that half received a cognitive therapy based interven-
tion and monitoring of mental state, and the other half received moni-
toring only. The intervention provided was based on a published
treatment manual, and focused on psychotic experiences, although in-
dividual goals and formulations would have varied (French and
Morrison, 2004). The cognitive therapy based intervention plus moni-
toringwas signiﬁcantly better thanmonitoringonly in reducing severity
of psychotic experiences, but not in reducing distress or transition to
psychosis over 12 to 24 months (Morrison et al., 2012).
Most relevant for current purposes, one of the questionnaires
assessed time spent asleep on ‘good’ and ‘bad’ nights over the previous
three months. This provides a measure of sleep duration, alongside an
indirect metric of the quality and variability of sleep by contrasting
the ‘good’ and ‘bad’ duration – thereby allowing sleep reporting beyond
endorsement of general sleep disturbance. As study assessments were
carried out every three months for a minimum of 12 months (and up
to 24months), the EDIE-2 dataset has themost assessment time points,
and longest follow up period, of any study recording sleep in the at-risk
population to date. Furthermore, the assessment of psychotic experi-
ences was carried out using the Comprehensive Assessment of At Risk
Mental States (CAARMS), in which the subscales of the ‘positive psy-
chotic experiences’ dimension allow measurement of individual psy-
chotic experiences (Yung et al., 2003). These design characteristics
support the use of this dataset for an opportunistic secondary analysis
of the relationship between sleep and individual psychotic experiences
over time in the at-risk group.
1.2. The current study
This study focuses on a secondary analysis of the EDIE-2 trial
dataset with the aim of testing if sleep disturbance is signiﬁcantly as-
sociated with more severe individual psychotic experiences cross-
sectionally and longitudinally in a cohort of individuals at-risk of
psychosis. A secondary aim was to test if sleep disturbance was
cross-sectionally associated with depression or lower quality of life
in this group.Sleep disturbance in this study is operationalised by using the ‘bad
night’ sleep duration and the difference (i.e. range) between the ‘bad
night’ and ‘good night’ sleep duration, as recorded in the EDIE-2 study
time use measure. The expectation is that a shorter bad night sleep du-
ration and larger range of sleep duration suggest secondary aspects of
sleep disturbance from sleep disorders. For example, insomnia would
be associatedwith short sleep duration, and often high variability (as in-
dividuals oversleep to catch up on sleep lost on bad nights). Circadian
rhythm disorders would also typically be associated with high variabil-
ity, and possible short duration, as the preferred sleep window clashes
with daily commitments.
2. Method
2.1. Participants
Two hundred and eighty-eight individuals aged 14–35 years partic-
ipated in the EDIE-2 trial. Participants were assessed with the CAARMS
to conﬁrm they fulﬁlled the inclusion criterion of being at-risk of psy-
chosis (intermittent psychotic symptoms, attenuated psychotic symp-
toms, or a decline in functioning alongside having a ﬁrst degree
relative with psychotic disorder). Exclusion criteria included current
or previous receipt of antipsychotic medication, moderate to severe
learning disability, organic impairment, and insufﬁcient ﬂuency in En-
glish. Half of the participants were assigned to cognitive therapy plus
monitoring of mental state and the other half to monitoring of mental
state only. All participants were followed up for a minimum of
12 months and a maximum of 24 months. For full details of trial design
and results see Morrison et al. (2011, 2012).
Sleep duration data were not retrievable from the Birmingham
(n = 60) or Cambridge (n = 20) trial sites. Participants without a
time point where both good sleep and bad sleep duration data
had been reported were also excluded (n = 48). This resulted in a
ﬁnal sample of 160 individuals for the current study.
2.2. Measures
2.2.1. Sleep
Self-reported sleep duration on ‘good’ and ‘bad’ nights over the past
three months was collected within the Economic Patient Questionnaire
interview (developed from the Time Use Survey; Short, 2006). Partici-
pants estimated their average sleep duration on ‘good’ and ‘bad’ nights
over the last three months. The bad night sleep duration, and the range
of sleep duration (i.e. the difference between the good and bad night
sleep durations) were used in the current study. This information was
collected at baseline, 3, 6, 9, 12, 15, 18, 21, and 24 months.
2.2.2. Psychotic experiences
The CAARMS (Yung et al., 2003) was the primary measure of
psychotic experiences in the EDIE-2 trial. The positive dimension was
used in the current study, which comprises four psychotic experience
subscales: Unusual Thought Content (UTC; e.g. ideas of reference, delu-
sional mood, thought insertion), Non-Bizarre Ideas (NBI; e.g.
persecutory ideas, grandiose ideas), Perceptual Abnormalities (PA; e.g.
visual or auditory changes) and Disorganised Speech (DS; e.g. circum-
stantial or tangential speech).
Each subscale is rated by the interviewer for severity (0 to 6 scale,
where 0 is not present and 6 is a clinical psychosis level), frequency
and duration (0 to 6 scale, where 0 is absent, and 6 is continuous),
and distress (0 to 100 scale, where 0 is not at all distressed, and
100 is extremely distressed). The severity and frequency are multi-
plied together to make a total severity score for the dimension. The
individual distress scores are averaged to produce an overall distress
score. Higher scores in all dimensions indicate greater severity, with
scores ranging from 0 to 36 for the severity subscales and 0 to 100 for
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18, 21, and 24 month assessments were used in the current study.
2.2.3. Depression and quality of life
Depression was assessed using the Beck Depression Inventory for
Primary Care (BDI-PC; Beck et al., 1997). This is a self-report question-
naire comprising 7 statements, rated on a 0 to 3 scale (where 0 is “Did
not apply to me”, and 3 is “Applied to me very much or all the time”).
The overall score is the sum of these items, of which the maximum
score is 21. The BDI-PC was completed at baseline, 6 months, and
12 months.
The Manchester Short Assessment of Quality of Life (MANSA; Priebe
et al., 1999) was used to measure satisfaction and quality of life. The
measure comprises 12 items in which the participant assesses satisfac-
tion in domains such as quality of friendships, ﬁnancial situation, and
physical health. Each item is rated on a 1 to 7 scale where 1 is a negative
extreme (“Couldn't beworse”), and 7 is a positive extreme (“Couldn't be
better”). The lowest possible score is 12, and the highest possible score
is 84, with higher scores indicating increased satisfaction and higher
quality of life. The MANSA was completed at baseline, 6 months and
12 months.
2.3. Analysis
All analyses were carried out using SPSS version 23 (IBM Corp.,
2015). First, descriptive statistics were calculated for all study mea-
sures, and used to observe trends over the study. Differences be-
tween treatment allocation groups for each study measure (from
all time points post-baseline) were then tested in independent sam-
ples t-tests.
The primary analysis approach was to run a set of pre-speciﬁed
stepped linear mixed effects models to address each of the study hy-
potheses, as listed below. All models were tested even if no relation-
ship was found at a prior phase. Linear mixed effects models allow
examination of within subject correlations cross-sectionally and lon-
gitudinally by nesting the observations within individuals and time
points, and allow use of all available data under the assumption
that data are missing at random. The threshold for signiﬁcance was
set at p ≤ 0.05 for all analyses. Site and treatment allocation were in-
cluded as factors in all models. A diagram of the analysis process can
be found in Fig. 1.Fig. 1. Analysis p2.3.1. Hypothesis 1: Shorter ‘Bad night’ sleep duration and wider range in
sleep duration will be associated with more severe psychotic experiences
Models were ﬁtted to each dimension of the CAARMS (UTC, NBI, PA,
DS, and Distress) with bad night sleep duration and sleep duration
range as factors to test this cross-sectional hypothesis.
2.3.2. Hypothesis 2: Previous shorter ‘Bad’ night sleep duration and wider
range in sleep duration will predict later psychotic experience severity
This hypothesis was tested in several stages as below, with each
stage acting as an increasingly conservative framing of the hypothesis
via addition of control variables.
Step 1: previous sleep disturbance variables as standalone predictors
In thisﬁrst step the longitudinal relationship between sleep and psy-
chotic experiences was assessed by testing previous bad night sleep du-
ration and sleepduration range as predictors of psychotic experiences at
the next assessment time point in a linear mixed effects model.
Step 2: controlling for later sleep disturbance
In the second step the sleep variables at the later assessment time
points were added to the model from Step 1. This allows a test of
whether the previous sleep variables are signiﬁcantly predictive of
later psychotic experiences, once the expected relationship between
sleep variables at the previous and later time points is controlled for.
Step 3: controlling for previous psychotic experience severity
In theﬁnal step previous psychotic experience severitywas added to
themodel fromStep2. This tested if the coefﬁcient of previous sleep dis-
turbance continued to be signiﬁcant when accounting for the expected
relationship between previous and current psychotic experiences (as
for the expected relationship between previous and current sleep as
tested in Step 2).
2.3.3. Hypothesis 3: Shorter ‘Bad night’ sleep duration and wider sleep du-
ration range will be associated with increased depression and reduced
quality of life
A cross-sectional linear mixed effects model (similar to
Hypothesis 1) was ﬁtted to depression (BDI-PC) and quality of life
(MANSA) outcomes.lan diagram.
Table 1
Demographics.
Age−mean (SD) 20.9 (4.2)
Gender− n (%)
Male 98 (61.1)
Female 62 (38.9)
Ethnicity− n (%)
White 147 (91.8)
Black (African/Caribbean/British/Other) 6 (3.8)
Asian (Indian/Pakistani/British/Chinese/Other) 3 (1.9)
Other 4 (2.5)
Randomisation− n (%)
Monitoring + cognitive therapy 80 (50.0)
Monitoring only 80 (50.0)
Table 3
Comparison between treatment groups on sleep, psychotic experiences, and wellbeing
(all time points except baseline).
Group means (SD) Independent
samples t-test
Monitoring only Monitoring and CBT t-value p-value
Sleep
BadDur 4.53 (3.3) 5.03 (3.0) −1.84 0.067
Range 3.82 (3.5) 2.97 (3.1) 2.93 0.004
CAARMS dimensions
Distress 19.24 (20.0) 17.33 (19.0) 1.53 0.127
UTC 4.73 (7.5) 3.39 (5.9) 3.15 0.002
NBI 6.66 (7.9) 6.28 (7.5) 0.78 0.435
PA 5.13 (6.5) 4.06 (5.7) 2.82 0.005
DS 3.38 (5.0) 3.26 (4.8) 0.39 0.696
Wellbeing
MANSA 58.28 (12.6) 56.34 (13.3) 1.19 0.237
BDI-PC 5.55 (4.8) 5.62 (4.9) −0.14 0.889
BadDur = Bad night sleep duration (hours).
Range = Sleep duration range (hours).
Data included from all time points except baseline.
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3.1. Demographic and descriptive data
Demographic information for the study group can be found in Table 1.
The groupwas predominantlymale (n=98, 61.1%), and the average age
was 20.7 years. The majority were white (n = 147, 91.8%). The study
groupwas balanced between interventions (n=80, 50%, in each group).
Descriptive statistics for all the study variables can be found in
Table 2. There was a general improvement in sleep over the study pe-
riod: bad night sleep duration slightly increased, and the sleep duration
range decreased. Bad night sleep duration was signiﬁcantly negatively
correlated with sleep duration range (r = −0.756, p b 0.001). There
was also a general improvement in psychotic experience severity and
distress across the study, and in depression and quality of life.
There were several signiﬁcant differences in outcomes between the
treatment groups, as can be seen in Table 3. The cognitive therapy group
had lower severity in the Unusual Thought Content and Perceptual Ab-
normality dimensions of the CAARMS than those who received moni-
toring alone. The group receiving cognitive therapy also had a
signiﬁcantly narrower range of sleep duration (p=0.004), and showed
a trend level signiﬁcance for longer bad night sleep duration (p =
0.067). No other signiﬁcant differences were found between the treat-
ment groups.Table 2
Descriptive statistics for the study measures.
Baseline 3 months 6 months 9 months 12
Mean (SD) N Mean (SD) N Mean (SD) N Mean (SD) N M
Sleep duration (h)
‘Good’
night
8.28 (2.5) 153 8.24 (2.2) 103 8.01 (2.2) 92 8.30 (2.4) 91 8.
‘Bad’ night 4.14 (3.4) 136 4.54 (2.8) 96 4.81 (3.3) 90 4.58 (2.7) 88 4.
Range 4.01 (3.6) 136 3.65 (3.1) 96 3.29 (3.1) 89 3.76 (3.4) 88 3.
CAARMS dimensions
UTC 8.26 (7.7) 160 3.91 (6.5) 119 3.69 (6.0) 115 3.49 (6.4) 105 3.
NBI 13.58
(7.1)
160 7.05 (7.4) 119 6.04 (6.8) 115 5.79 (6.9) 105 6.
PA 10.11
(7.1)
160 5.49 (6.1) 119 4.72 (6.1) 115 4.79 (5.6) 106 4.
DS 4.23 (4.8) 160 2.73 (4.1) 119 2.10 (3.6) 115 2.44 (4.0) 105 3.
Distress 43.19
(20.8)
153 23.41
(22.1)
111 18.81
(20.9)
111 19.78
(20.4)
103 19
(1
Wellbeing
MANSA 50.3
(10.7)
122 54.98
(11.7)
84 56
(1
BDI-PC 10.16
(4.4)
148 6.25 (4.6) 108 6.
CAARMS=Comprehensive Assessment of At RiskMental States; UTC=Unusual Thought Cont
BDI-PC – Beck Depression Inventory for Primary Care; MANSA =Manchester Short Assessmen3.2. Relationship between sleep and psychotic experiences
3.2.1. Hypothesis one: a cross-sectional model
The results from this analysis are summarised in Table 4. Shorter bad
night sleep durationwas signiﬁcantly associatedwith increased severity
of non-bizarre ideas (NBI), perceptual abnormalities (PA), and psy-
chotic experience distress. Narrower range of sleep duration was signif-
icantly related to increased severity of NBI. No signiﬁcant relationships
between bad night sleep duration or sleep duration range were found
for either unusual thought content (UTC) or disorganised speech (DS)
in this cross-sectional model.
In summary, a shorter bad night sleep durationwas cross-sectionally
associated with increased delusional ideas and hallucinations (and dis-
tress) as hypothesised. However, narrower sleep rangewas signiﬁcantly
related to increased severity of delusional ideas, contrary to our
hypothesis.months 15 months 18 months 21 months 24 months
ean (SD) N Mean (SD) N Mean (SD) N Mean (SD) N Mean (SD) N
23 (2.2) 94 8.32 (2.3) 57 7.79 (2.5) 47 8.37 (2.0) 41 7.65 (1.6) 37
45 (2.9) 91 5.27 (3.4) 52 4.94 (3.8) 40 5.49 (3.6) 40 4.99 (3.5) 36
82 (3.3) 90 3.07 (3.4) 52 2.89 (4.5) 40 2.90 (3.5) 39 2.73 (3.0) 35
93 (6.9) 109 3.06 (5.7) 65 3.09 (6.6) 55 2.65 (4.8) 48 2.00 (4.5) 43
30 (8.0) 109 6.20 (6.9) 65 5.07 (6.7) 55 6.40 (7.4) 48 6.93 (9.0) 43
90 (6.6) 108 4.23 (6.0) 65 4.25 (6.6) 55 4.54 (7.5) 48 5.16 (7.5) 43
41 (4.8) 109 2.52 (4.1) 65 2.51 (3.4) 55 3.06 (4.7) 48 4.37 (6.9) 43
.53
7.9)
105 18.86
(21.3)
63 16.09
(19.2)
54 19.36
(22.6)
48 18.89
(21.3)
40
.42
3.3)
84
63 (5.2) 103
ent; NBI=Non-Bizarre Ideas; PA=Perceptual Abnormalities; DS=Disorganised Speech;
t of Quality of Life.
Table 4
Mixed effect model output – hypothesis one (cross-sectional only).
Factor Estimate Std. Error df t p 95% conﬁdence interval
Lower bound Upper bound
Unusual thought content BadDur −0.059 0.11 541.9 −0.52 0.602 −0.28 0.16
Range −0.010 0.11 583.8 −0.09 0.926 −0.23 0.21
Non-bizarre ideas BadDur −0.402 0.14 610.3 −2.88 0.004 −0.68 −0.13
Range −0.331 0.13 578.0 −2.53 0.012 −0.59 −0.07
Perceptual abnormalities BadDur −0.327 0.13 615.7 −2.59 0.010 −0.57 −0.08
Range 0.003 0.12 600.2 0.02 0.983 −0.23 0.24
Disorganised speech BadDur −0.041 0.08 612.5 −0.53 0.596 −0.19 0.11
Range 0.026 0.07 586.5 0.36 0.719 −0.12 0.17
Distress BadDur −1.170 0.42 589.8 −2.79 0.005 −1.99 −0.35
Range −0.415 0.39 566.1 −1.07 0.287 −1.18 0.35
BadDur = Bad night sleep duration (hours).
Range = Sleep duration range (hours).
Treatment allocation and site controlled for in all analyses.
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3.2.2.1. Step 1: a longitudinal model. The results from this analysis are
summarised in Table 5. The longitudinal relationships were similar to
those in the cross-sectionalmodel in that therewere signiﬁcant relation-
ships between previous shorter bad night sleep duration and increased
severity of later NBI and PA, although the relationship with distress did
not reach signiﬁcance when tested longitudinally (p= 0.078). Smaller
sleep duration range at the previous time point was signiﬁcantly related
to increased severity of later NBI. No signiﬁcant relationshipswere found
between the previous sleep variables and later UTC or DS.
These results suggest that shorter bad night sleep duration is a sig-
niﬁcant predictor of later delusional ideas and hallucinations. Narrower
sleep range was associated with increased severity of later delusional
ideas, again contrary to hypothesis.3.2.2.2. Step 2: a longitudinal model controlling for later sleep. The results
from this analysis can be found in Table 6. Previous short bad night
sleep duration remained a signiﬁcant predictor for later NBI, even
once sleep at the later time point was controlled for. However, neither
bad sleep duration nor sleep duration range (at either the previous or
later time point) had a signiﬁcant predictive effect on other psychotic
experience severities.
These ﬁndings suggest that the relationship between previous sleep
disturbance and later hallucinations may be accounted for previous
sleep disturbance predicting later sleep disturbance. However, previous
bad night sleep duration was still a signiﬁcant additional predictor of
later delusional ideas, even once sleep disturbance at the later time
point was accounted for.Table 5
Mixed effect model output – hypothesis two (step one -without current sleep control).
Factor Estimate Std. Error
Psychotic Experiences (CAARMS)
Unusual thought content t-1_BadDur −0.167 0.13
t-1_Range −0.154 0.12
Non-bizarre ideas t-1_BadDur −0.432 0.15
t-1_Range −0.281 0.14
Perceptual abnormalities t-1_BadDur −0.324 0.14
t-1_Range 0.009 0.13
Disorganised speech t-1_BadDur −0.116 0.09
t-1_Range 0.005 0.08
Distress t-1_BadDur −0.812 0.46
t-1_Range −0.369 0.43
BadDur = Bad night sleep duration (hours).
Range = Sleep duration range (hours).
t-1 = from previous time point.
Treatment allocation and site controlled for in all analyses.3.2.2.3. Step 3: a longitudinalmodel controlling for previous psychotic expe-
rience severity. Table 7 shows the results from this phase of analysis. In
all cases the previous severity of each psychotic experience is a signiﬁ-
cant positive predictor of later severity of that psychotic experience.
The only sleep relationship remaining signiﬁcant in these ﬁnal models
is a cross-sectional relationship between shorter bad night sleep and
more severe NBI. No previous sleep disturbance variables remained sig-
niﬁcant predictors once previous psychotic experienceswere accounted
for.
This ﬁnal set ofmodels therefore suggest that previous psychotic ex-
perience is a stronger predictor than previous sleep disturbance for later
psychotic experiences, with no evidence of a unique contribution of
sleep disturbance across time for predicting change in psychotic
experiences.
3.2.3. Hypothesis three: sleep and psychological wellbeing
The outcome of this stage of analysis can be seen in Table 8. Neither
bad night sleep duration, nor sleep duration range, were signiﬁcantly
associated with depression or quality of life in these cross-sectional
models.
4. Discussion
The aim of this study was to utilise a large dataset to perform an op-
portunistic investigation of the relationship between sleep duration and
psychotic experiences in patients at high risk of psychosis. As
hypothesised, shorter sleep duration on bad nights was cross-
sectionally associated with signiﬁcantly more delusional ideas and hal-
lucinations, and with higher levels of distress from psychotic experi-
ences. However, a smaller sleep duration range was associated withdf t p 95% Conﬁdence Interval
Lower Upper
464.5 −1.31 0.190 −0.42 0.08
446.4 −1.28 0.202 −0.39 0.08
440.7 −2.96 0.003 −0.72 −0.14
393.7 −2.07 0.039 −0.55 −0.01
467.5 −2.39 0.017 −0.59 −0.06
458.6 0.07 0.947 −0.24 0.26
465.9 −1.35 0.178 −0.29 0.05
437.3 0.06 0.954 −0.15 0.16
469.8 −1.77 0.078 −1.71 0.09
444.2 −0.86 0.389 −1.21 0.47
Table 6
Mixed effect model output – hypothesis two (step two - with current sleep control).
Factor Estimate Std. Error df t p 95% Conﬁdence Interval
Lower Upper
Unusual Thought Content BadDur −0.052 0.15 327.9 −0.34 0.736 −0.36 0.25
Range 0.005 0.14 395.2 0.04 0.971 −0.27 0.28
t-1_BadDur −0.132 0.15 341.1 −0.89 0.374 −0.42 0.16
t-1_Range −0.106 0.14 381.0 −0.77 0.443 −0.38 0.17
Non-Bizarre Ideas BadDur −0.384 0.18 368.9 −2.10 0.036 −0.74 −0.02
Range −0.401 0.16 374.1 −2.51 0.012 −0.71 −0.09
t-1_BadDur −0.383 0.18 390.6 −2.18 0.030 −0.73 −0.04
t-1_Range −0.193 0.16 372.8 −1.23 0.220 −0.50 0.12
Perceptual Abnormalities BadDur −0.184 0.17 399.6 −1.06 0.291 −0.53 0.16
Range 0.077 0.15 402.0 0.51 0.613 −0.22 0.38
t-1_BadDur −0.259 0.17 409.4 −1.56 0.121 −0.59 0.07
t-1_Range 0.018 0.15 397.0 0.12 0.902 −0.28 0.31
Disorganised Speech BadDur −0.052 0.11 402.8 −0.47 0.637 −0.27 0.16
Range 0.002 0.09 369.8 0.02 0.986 −0.18 0.19
t-1_BadDur −0.030 0.11 414.4 −0.29 0.775 −0.24 0.18
t-1_Range 0.062 0.09 379.8 0.67 0.503 −0.12 0.25
Distress BadDur −1.080 0.58 386.5 −1.87 0.062 −2.22 0.05
Range −0.409 0.49 373.4 −0.83 0.406 −1.37 0.56
t-1_BadDur −0.146 0.54 393.9 −0.27 0.788 −1.22 0.92
t-1_Range 0.101 0.48 354.2 0.21 0.833 −0.84 1.04
BadDur = Bad night sleep duration (hours).
Range = Sleep duration range (hours).
t-1 = from previous time point.
Treatment allocation and site controlled for in all analyses.
331S. Reeve et al. / Schizophrenia Research 204 (2019) 326–333more severe delusional ideas, contrary to the hypothesised positive as-
sociation. Similar relationships were present longitudinally, with shorter
bad night sleep duration at the previous time point predicting later sever-
ity of hallucinations and delusional ideas, as hypothesised. However,
when additional controls were added these relationships did not remain
signiﬁcant. Overall the results support further investigation in to the rela-
tionship between sleep disturbance and individual psychotic experiences.
The signiﬁcant associations between reduced bad night sleep dura-
tion and increased delusional ideas and hallucinations in the present
study are consistent with the links between reduced sleep andTable 7
Mixed effect model output – hypothesis two (step three –with controls for current sleep and
Factor Estimate Std. Error
Unusual Thought Content BadDur −0.121 0.14
Range 0.009 0.12
t-1_BadDur 0.009 0.13
t-1_Range −0.031 0.12
t-1_UTC 0.395 0.04
Non-Bizarre Ideas BadDur −0.365 0.16
Range −0.226 0.14
t-1_BadDur −0.036 0.15
t-1_Range −0.059 0.13
t-1_NBI 0.477 0.04
Perceptual Abnormalities BadDur −0.181 0.16
Range 0.070 0.14
t-1_BadDur −0.082 0.15
t-1_Range −0.032 0.14
t-1_PA 0.406 0.04
Disorganised Speech BadDur −0.051 0.11
Range −0.013 0.09
t-1_BadDur −0.011 0.10
t-1_Range 0.034 0.09
t-1_DS 0.286 0.05
Distress BadDur −1.158 0.60
Range −0.424 0.50
t-1_BadDur −0.037 0.57
t-1_Range 0.194 0.49
t-1_Distress 0.032 0.01
BadDur = Bad night sleep duration (hours).
Range = Sleep duration range (hours).
t-1 = from previous time point.
Treatment allocation and site controlled for in all analyses.increased paranoia and hallucinations as reported in a previous experi-
mental study (Reeve et al., 2018). The association between narrower
range and increased psychotic experiences was contrary to the study
hypothesis, and appears inconsistent with previous studies that have
reported a link between increased sleep variability and psychotic expe-
riences (Lunsford-Avery et al., 2016; Waters et al., 2011). However, in
the context of the bad night sleep duration results the most consistent
interpretation is that overall low sleep duration (i.e. short sleep on
good and bad nights) is associated with more severe psychotic
experiences.previous psychotic experience).
df t p 95% conﬁdence interval
Lower Upper
332.3 −0.87 0.385 −0.39 0.15
351.0 0.07 0.944 −0.23 0.25
342.4 0.06 0.949 −0.25 0.27
357.1 −0.26 0.798 −0.27 0.21
370.5 10.23 0.000 0.32 0.47
387.3 −2.28 0.023 −0.68 −0.05
369.3 −1.64 0.101 −0.50 0.04
397.9 −0.23 0.816 −0.34 0.27
355.2 −0.43 0.664 −0.32 0.21
389.5 12.59 0.000 0.40 0.55
402.4 −1.14 0.256 −0.49 0.13
386.9 0.51 0.614 −0.20 0.34
404.3 −0.54 0.589 −0.38 0.22
386.2 −0.23 0.815 −0.30 0.23
401.4 9.88 0.000 0.33 0.49
399.6 −0.48 0.629 −0.26 0.16
354.9 −0.15 0.883 −0.19 0.17
413.0 −0.11 0.911 −0.21 0.19
375.7 0.38 0.703 −0.14 0.21
381.5 6.25 0.000 0.20 0.38
371.5 −1.92 0.056 −2.35 0.03
349.7 −0.84 0.400 −1.41 0.57
377.3 −0.07 0.948 −1.15 1.08
332.1 0.40 0.691 −0.76 1.15
83.4 2.36 0.020 0.01 0.06
Table 8
Mixedeffectmodel output –hypothesis three (cross-sectional, depression andquality of life).
Factor Estimate Std.
Error
df t p 95% conﬁdence
interval
Lower
bound
Upper
bound
Depression
(BDI-PC)
BadDur −0.161 0.13 288.5 −1.21 0.226 −0.42 0.10
Range −0.013 0.13 289.4 −0.10 0.920 −0.26 0.24
Quality of
Life
(MANSA)
BadDur 0.332 0.34 224.3 0.98 0.330 −0.34 1.00
Range 0.084 0.34 231.0 0.25 0.806 −0.59 0.76
BadDur = Bad night sleep duration (h).
Range = Sleep duration range (h).
Treatment allocation and site controlled for in all analyses.
BDI-PC – Beck Depression Inventory for Primary Care; MANSA = Manchester Short As-
sessment of Quality of Life.
332 S. Reeve et al. / Schizophrenia Research 204 (2019) 326–333These ﬁndings are consistent with theoretical models for sleep dis-
ruption and psychosis in the at-risk group. In onemodel sleep/wake dis-
turbances are seen as both reﬂecting an underlying biological
vulnerability and as an additional stressor. In other words, sleep distur-
bances are thought to initiate a vicious cycle wherein disrupted sleep
leads to increased psychotic experiences, the distress from which dis-
rupts sleep further (Lunsford-Avery and Mittal, 2013). It is also worth
noting that participants who received the cognitive therapy interven-
tion showed more improvement in sleep over the study period (as
well as signiﬁcantly less severe psychotic experiences). This supports a
parallel between improving psychotic experiences and improved
sleep, which could be investigated more directly with a sleep interven-
tion study. A recent pilot case serieswith an at-risk population indicated
that treating sleep problems did result in decreases in psychotic experi-
ences and negative affect (Bradley et al., 2018). Sleep treatment there-
fore represents an exciting new possibility for at-risk intervention.
No signiﬁcant relationships were found between the sleep variables
and the psychotic experience dimensions of unusual thought content or
disorganised speech, which indicates that the relationship between
sleep disturbance and psychotic experiences may be somewhat selec-
tive, as has been reported elsewhere (Reeve et al., 2018). The ﬁndings
from this study further support the importance of measuring individual
psychotic experiences separately when investigating the inﬂuence of
sleep.
The non-signiﬁcant relationship between depression and either
measure of sleep disturbance in the results is surprising. This is contrary
to previous ﬁndings indicating negative affect as amediator in the sleep
disturbance andpsychosis relationship (e.g. Reeve et al., 2018), and con-
trary to a general literature linking sleep disturbance with depression
(Murphy and Peterson, 2015). The BDI-PC scale used in the current
study is typically used as a screening tool with a categorical outcome
(with scores ≥4 indicating major depression). Notably, the majority of
the participants were above this cut-off throughout the trial. Neverthe-
less, as these scores were used dimensionally, this measure may have
lacked sensitivity to detect changes. The null relationship between
sleep and quality of life is also unexpected. Sleep problems reduce qual-
ity of life (Kyle et al., 2010a, 2010b), and sleep and quality of life have
both been linked to psychotic symptoms in clinical groups (Afonso
et al., 2011). A potential explanation could be that fatigue ismore linked
than sleep to functional health (Waters et al., 2013), however as there
was nomeasure of fatigue in the current study it was not possible to as-
sess this. The null ﬁnding in both depression and quality of life could
also be related to lower power in these tests, given the lower rate of
completion of these measures.
Oneworthwhile issue to investigate iswhether disrupted sleep is as-
sociatedwith transition to psychosis. Thiswas not possible to test in this
study as there was a very low transition rate to psychosis in the group
(9.4%), lower than expected in a group of individuals fulﬁlling the at-
risk criteria (typically N16%; Hartmann et al., 2016; Yung et al., 2008).This transition rate could have been lower due to a positive effect of the
study monitoring on improving psychotic experiences. Indeed, as can be
seen in the descriptive measures both study groups showed improve-
ments in severity of psychotic experiences and othermeasures over time.4.1. Limitations
Similar to previous large studies from the at-risk literature (Miller
et al., 2003; Poe et al., 2017; Ruhrmann et al., 2010), the EDIE-2 study
did not have sleep as a focus. However, one advantage of the current
study is that the sleep information is not a single sleep quality judge-
ment as in the SAPS, but gives duration information. It is alsoworth not-
ing that youth at risk of psychosis have elsewhere been found to be
accurate self-reporters of sleep duration (Lunsford-Avery et al., 2015).
Secondly, in this study sleep information was collected at up to nine
time points over two years. As a result, this goes beyond previous sec-
ondary analysis studies where sleep information was only collected at
a maximum of two time points.
The sleep duration estimates have some limitations as measures of
sleep disturbance. For example, the frequency of good nights versus bad
nights was not assessed, which would have allowed calculation of an av-
erage sleep time and variability of sleep. The duration variable also does
not give context on the timing of sleep, which is important as circadian
dysfunction is commonly reported in individuals with psychosis (Wulff
et al., 2012), and has been found to be predictive of positive symptoms
in individuals at risk of psychosis (Lunsford-Avery et al., 2016).
One limitation in the statistical approach is co-linearity among the
predictors. The two sleep variables were negatively correlated, such
that individualswith shorter bad sleep duration had awider sleep dura-
tion range (as would be expected within a common insomnia presenta-
tion). Sleep variables were also highly correlated over time. This
decreases the possibility that individual variableswill emerge as predic-
tors of variance in the outcome (i.e. psychotic experience severity). One
way to reduce this effect is tomean centre the variableswithin each par-
ticipant. However, in the present study differences between the starting
position for each participant is non-arbitrary (e.g. a change from 8 h to
6 h sleep on a bad night is unlikely to have the same effect as a change
from 6 h to 4 h), therefore this option was not appropriate. Another
way to remove this issue is to induce changes in the predictor variable
across time (e.g. by providing an intervention), as in the pilot trial re-
cently reported by Bradley et al. (2018).
A separate statistical limitation in this study is the need to control for
site and treatment allocation, which will have reduced the power avail-
able to detect other effects in the remaining variance. This may have
contributed to the low signiﬁcance of the relationships reported,
which in many cases would not survive conservative corrections for
multiple testing. However, given that the approach here is of planned
comparisons, where all analyses are pre-speciﬁed, it is not necessarily
appropriate to apply these corrections (Feise, 2002; Schulz and
Grimes, 2005). Furthermore, it was not possible to control for age or oc-
cupational status, which are likely to be a source of signiﬁcant variance
in sleep as reported in the current study. Substance abuse was also not
accounted for in the current study.
Overall the ﬁndings show that sleep disturbance, even when indi-
rectly measured, acts as a signiﬁcant longitudinal predictor of later psy-
chotic experiences in the at-risk population (up until the most
conservative corrections are made). Prediction of clinical trajectories is
particularly valuable for the at-risk group, therefore a possible role of
sleep disturbance in predicting later outcomes deserves further investi-
gation. This study also supports the potential importance of treating
sleep disturbance in this group, a possibility now beginning to be ex-
plored in the clinical literature (Bradley et al., 2018). Future studies
should investigate the effectiveness of these interventions on psychotic
symptoms, and assess sleep disorder symptoms in clinical groups in
order to reﬁne intervention targets.
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